findmyKOL
Clinical trialNCT06797518RecruitingPhase 2Interventional

Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN

SponsorNovartis PharmaceuticalsEnrollment20Glomerulonephritis, IGAImmunoglobulin A Nephropathy
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Argentina
  • Novartis Investigative Site

    CABA, Buenos Aires, Argentina

    Recruiting
  • Novartis Investigative Site

    CABA, Buenos Aires, Argentina

    Recruiting
  • Novartis Investigative Site

    Córdoba, Córdoba Province, Argentina

    Recruiting
Israel
  • Novartis Investigative Site

    Ashdod, Israel

    Recruiting
  • Novartis Investigative Site

    Hadera, Israel

    Recruiting
  • Novartis Investigative Site

    Haifa, Israel

    Recruiting
  • Novartis Investigative Site

    Nahariya, Israel

    Recruiting
Malaysia
  • Novartis Investigative Site

    Kuala Lumpur, Selangor, Malaysia

    Recruiting
Saudi Arabia
  • Novartis Investigative Site

    Riyadh, Saudi Arabia

    Recruiting
United States
  • University of Alabama at Birmingham

    Birmingham, Alabama, United States

    Dana Rizk
    Recruiting
  • Ucla Medical Center

    Los Angeles, California, United States

    Mrinalini Sarkar
    Recruiting
  • Central Florida Kidney Specialists

    Orlando, Florida, United States

    Arvind Madan
    Recruiting
  • Georgia Nephrology Research Inst

    Lawrenceville, Georgia, United States

    James A Tumlin
    Recruiting
  • Care Research

    Chubbuck, Idaho, United States

    Hira Siktel
    Recruiting
  • Davita Clinical Research

    Las Vegas, Nevada, United States

    Mark Vishnepolsky
    Recruiting
  • University Hospitals Cleveland Medical Center

    Cleveland, Ohio, United States

    Andrew Lazar
    Recruiting
  • Osu Wexner Medical Center

    Columbus, Ohio, United States

    Isabelle Ayoub
    Recruiting
  • Prolato Clinical Research Center

    Houston, Texas, United States

    Sreedhar Mandayam
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
21 Feb 2025
Primary completion
27 Nov 2027
Completion
27 Nov 2027
Last update posted
27 Apr 2026
Registered enrollment
20
Registry id
NCT06797518

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.